Replies to post #85 on Navidea Biopharmaceuticals Inc (NAVB)

[drbio45]

dew,

apprecitate the posting of the 10-k but disagree with the valuation being fully priced.

You are saying that to continue the rigs to fruition would cause a dilutive financing.

If they get the proper guidance from the FDA don't you believe that a partner would come in to finish what is neccessay to get this thing commercialized.

you and I certainly aren't in genaera thinking that genr will be selling stock to finance the amd trials. We are waiting for a huge deal.

The same will happen here. The rigs process is a potential 500 million to billion dollar product and you interpretation that it is fully valued is incorrect

imho